Yan Xie

2.6k total citations
78 papers, 1.3k citations indexed

About

Yan Xie is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Yan Xie has authored 78 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 35 papers in Oncology and 16 papers in Neurology. Recurrent topics in Yan Xie's work include Lymphoma Diagnosis and Treatment (50 papers), Viral-associated cancers and disorders (22 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Yan Xie is often cited by papers focused on Lymphoma Diagnosis and Treatment (50 papers), Viral-associated cancers and disorders (22 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Yan Xie collaborates with scholars based in China, Ethiopia and Australia. Yan Xie's co-authors include Jun Zhu, Yuqin Song, Zee Upton, Wen Zheng, Xiaopei Wang, Ningjing Lin, David I. Leavesley, Lingyan Ping, Weiping Liu and Zhitao Ying and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.

In The Last Decade

Yan Xie

68 papers receiving 1.3k citations

Peers

Yan Xie
Comparison fields: 5 of 103
  • Oncology 520
  • Pathology and Forensic Medicine 441
  • Molecular Biology 259
  • Immunology 231
  • Rehabilitation 190
Replace Ahmad Waseem with:
Ahmad Waseem United Kingdom
Stefanie Löffek Germany
Manuel Navarro Spain
Michael K. Lichtman United States
Sebastian Willenborg Germany
Cornelia Tölg Canada
Jo Louise Seltzer United States
Yingjun Su China
Stephan Sollberg Germany
Sylvie Brassart‐Pasco France
Ahmad Waseem United Kingdom View profile →
Citations per field, relative to Yan Xie
Yan Xie · 1×
Citations per year, relative to Yan Xie
Yan Xie · 1×

Countries citing papers authored by Yan Xie

Since Specialization
Citations

This map shows the geographic impact of Yan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xie more than expected).

Fields of papers citing papers by Yan Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xie. The network helps show where Yan Xie may publish in the future.

Co-authorship network of co-authors of Yan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xie. A scholar is included among the top collaborators of Yan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xie. Yan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 50
4 4
5 0
6
Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway
1
7 8
8 11
9 28
10 6
11 11
12 23
13 7
14 29
15 18
16
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
5
17 85
18
Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma.
0
19 69
20 98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026